ReviewFrontiers in pediatrics2026
Advancements in diagnosis, preventive care, and future directions in the holistic management of pediatric asthma.
Review in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric asthma is a highly prevalent chronic respiratory disorder characterized by airway inflammation, hyperreactivity, and variable airflow limitation, resulting in significant global health and socioeconomic burdens. Advances in diagnosis, including the measurement of fractional exhaled nitric oxide, assessment of blood eosinophils, and artificial intelligence-assisted tools, have improved early detection and disease stratification. Optimal management combines planned daily care, which includes systematic symptom monitoring, adherence to prescribed medications, frequent physical activity, and the promotion of adequate sleep. Targeted preventative methods, including allergy avoidance, viral infection prophylaxis, air quality improvement, and lifestyle optimization, reduce exacerbation risk and promote long-term control. Multiple variables influence pediatric asthma outcomes, including genetic predisposition, environmental exposures, and social determinants, emphasizing the significance of coordinated care among caregivers, schools, and multidisciplinary healthcare teams. Stepwise pharmacological and non-pharmacological therapies provide tailored treatment options for severe or refractory conditions. Persistent barriers to healthcare access, disparities in disease burden, and issues with treatment adherence underline the need for creative solutions. Emerging approaches, such as digital self-management tools, precision-based prevention strategies, and community-level interventions, present prospects to improve disease control. Effective asthma care goes beyond pharmacological treatment, focusing on early intervention, personalized support, and equitable access to improve children's long-term respiratory health and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.